DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Taro Pharmaceutical Industries
03 1Strides Pharma Science
04 1Bal Pharma
05 1ALTANA
06 5Actavis Inc
07 1Aldo-Union
08 2Alembic Pharmaceuticals Limited
09 2Alkem Laboratories
10 2Almirall
11 17Amdipharm Mercury Company Limited
12 5Amneal Pharmaceuticals
13 3Arbor Pharmaceuticals
14 1Astellas Pharma
15 8Azurity Pharma
16 4Barr Laboratories
17 6Bausch & Lomb Incorporated
18 2Bausch Health
19 1Bio Labs
20 1Biofrontera
21 3Bristol Myers Squibb
22 3Eli Lilly
23 2Encube Ethicals
24 2Epic Pharma. LLC.
25 1Farmatek
26 2Fisiopharma S.r.l.
27 4Focelite
28 4Fougera Pharmaceuticals Inc.
29 2Galderma
30 1Hospira, Inc.
31 3IDI FARMACEUTICI Srl
32 1IVAX Pharmaceuticals Inc
33 1Johnson & Johnson
34 1Keko Pharmaceutical Industries
35 1LA.FA.RE. Srl
36 2Laboratorios Poen
37 6Meda - Asker
38 1Meda AB
39 2Meenaxy Pharma Pvt. Ltd
40 1Merz Pharma
41 1Micro Labs Limited
42 1NEW RESEARCH Srl
43 2NORVIUM BIOSCIENCE
44 2NoroBio Pharmaceutical
45 1PAI Pharmaceutical Associates
46 1PANPHARMA
47 1PHARMOBEDIENT CNSLTG
48 4Padagis
49 1Perrigo Company plc
50 3Pfizer Inc
51 1Pharmaderm
52 2Pluviaendo
53 1ROBINS AH
54 1Renaissance Pharma
55 1Rising Pharmaceuticals Inc
56 1SYOSSET
57 1Sentiss Pharma
58 1Solvay Chemicals International S.A
59 1Stiefel
60 1Stragen Pharma SA
61 2Teva Pharmaceutical Industries
62 2Theon Pharmaceuticals
63 5Torrent Pharmaceuticals Limited
64 1Vaishali Pharma Ltd
65 1Viatris
66 1Warner Chilcott Company, LLC
67 1Winston Medical Supply
68 1Xepa-Soul Pattinson m SDN BHD
69 1Zim Laboratories
70 4Zydus Lifesciences
71 2Zydus Pharmaceuticals
72 6Blank
01 3Antic-calc Tablet, Film Coated
02 8CAPSULE, DELAYED REL PELLETS;ORAL
03 2Capsule
04 1DRY SUSPENSION
05 1ENTEROKAPSEL, HÅRD
06 4Enteric Tablet
07 1Erythromycin 0.1% 50Ml Oral Use
08 1Erythromycin 1.000Mg 1 Unit Parenteral Use
09 1Erythromycin 1.000Mg 6 Combined Oral Use
10 1Erythromycin 10% 100Ml Oral Use
11 1Erythromycin 200Mg 12 Combined Oral Use
12 1Erythromycin 500Mg 1 Unit Parenteral Use
13 2Erythromycin 500Mg 12 Combined Oral Use
14 1Erythromycin 600Mg 12 Combined Oral Use
15 5Eye Ointment
16 2Film Coated Tablet
17 10GEL;TOPICAL
18 3Gel
19 7Granules to potion, suspension
20 1LOTION;TOPICAL
21 6OINTMENT;OPHTHALMIC
22 1OINTMENT;TOPICAL
23 1ORAL SUSPENSION
24 3Ointment
25 1Ophthalmic Solution
26 1POWDER FOR SOLUTION FOR INFUSION
27 1POWDER;FOR RX COMPOUNDING
28 1Powder for Solution for Infusion
29 2Powder for infusion fluid, resolution
30 23SOLUTION;TOPICAL
31 7SWAB;TOPICAL
32 3Solution
33 1TABLET
34 2TABLET, COATED PARTICLES;ORAL
35 17TABLET, DELAYED RELEASE;ORAL
36 18TABLET;ORAL
37 11Tablet
38 8Blank
01 56DISCN
02 3Generic
03 38RX
04 66Blank
01 12% 70G Deripil Gel
02 12% 70G Loderm Gel
03 12% 70Ml Deripil Solution
04 12% 70Ml Loderm Topical Solution Extemporaneous
05 1A/T/S
06 1AKNE-MYCIN
07 1AKTIPAK
08 7Abboticin
09 3Abboticin ES
10 1Abboticin Novum
11 1Akne-mycin
12 1Akne-mycin 2000
13 1BENZAMYCIN
14 2C-SOLVE-2
15 1DIOMYCIN
16 3E-BASE
17 1E-GLADES
18 2E-MYCIN
19 1E-SOLVE 2
20 1EMGEL
21 3ERY-TAB
22 4ERYC
23 1ERYC 125
24 1ERYC SPRINKLES
25 1ERYCETTE
26 1ERYDERM
27 1ERYGEL
28 1ERYMAX
29 1ERYTHRA-DERM
30 1ERYTHRO-STATIN
31 53ERYTHROMYCIN
32 2ERYTHROMYCIN AND BENZOYL PEROXIDE
33 6Eritrocina
34 2Eritrofarm
35 1Eritrogobens Tablets 500Mg 30 Tablets
36 7Ery-Max
37 1Eryacne
38 1Erycin
39 1Erymac
40 1Erysol OS
41 4Erythromycin
42 1Erythromycin ESTEDI
43 2Erythromycin Lactobionate
44 1Erythromycin Panpharma
45 2Ethomex
46 2ILOTYCIN
47 1Isotrexin
48 2Lauromicina
49 2PCE
50 1Pantomicina Carise E. S 500Mg 30 Tablets
51 1R-P MYCIN
52 1ROBIMYCIN
53 1SANSAC
54 1STATICIN
55 2T-STAT
56 1THEOMYCIN-250
57 1THEOMYCIN-500
58 1Zineryt
59 14Blank
01 2Argentina
02 2China
03 12India
04 17Italy
05 1Malaysia
06 16Norway
07 1Pakistan
08 7Spain
09 3Sweden
10 2Switzerland
11 1Taiwan
12 1Tanzania
13 3Turkey
14 94USA
15 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERYC
Dosage Form : CAPSULE, DELAYED REL PELLETS;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 50536
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info : Generic
Registration Country : India
Brand Name : Erycin
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : A/T/S
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1982-11-18
Application Number : 62405
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1982-04-19
Application Number : 62326
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1982-04-19
Application Number : 62327
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 1.5%
Packaging :
Approval Date : 1982-04-19
Application Number : 62328
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : E-MYCIN
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 60272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : E-MYCIN
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 333MG
Packaging :
Approval Date : 1982-01-01
Application Number : 60272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYDERM
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1982-01-01
Application Number : 62290
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PCE
Dosage Form : TABLET, COATED PARTICLES;ORAL
Dosage Strength : 333MG
Packaging :
Approval Date : 1986-09-09
Application Number : 50611
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PCE
Dosage Form : TABLET, COATED PARTICLES;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1990-08-22
Application Number : 50611
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61621
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61621
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERY-TAB
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 62298
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERY-TAB
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1982-01-01
Application Number : 62298
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERY-TAB
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 333MG
Packaging :
Approval Date : 1982-03-29
Application Number : 62298
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AKNE-MYCIN
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1985-01-10
Application Number : 50584
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BENZOYL PEROXIDE; ERYTHROMYCIN
Brand Name : BENZAMYCIN
Dosage Form : GEL;TOPICAL
Dosage Strength : 5%;3%
Packaging :
Approval Date : 1984-10-26
Application Number : 50557
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
BENZOYL PEROXIDE; ERYTHROMYCIN
Brand Name : AKTIPAK
Dosage Form : GEL;TOPICAL
Dosage Strength : 5%;3%
Packaging :
Approval Date : 2000-11-27
Application Number : 50769
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : STATICIN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50526
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ILOTYCIN
Dosage Form : OINTMENT;OPHTHALMIC
Dosage Strength : 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50368
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1982-01-01
Application Number : 50532
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ILOTYCIN
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61910
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYC SPRINKLES
Dosage Form : CAPSULE, DELAYED REL PELLETS;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 1985-07-22
Application Number : 50593
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYCETTE
Dosage Form : SWAB;TOPICAL
Dosage Strength : 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1985-02-15
Application Number : 50594
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERYTHROMYCIN
Dosage Form : POWDER;FOR RX COMPOUNDING
Dosage Strength : 100%
Packaging :
Approval Date : 1986-11-07
Application Number : 50610
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : R-P MYCIN
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61659
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERYGEL
Dosage Form : GEL;TOPICAL
Dosage Strength : 2%
Packaging :
Approval Date : 1987-10-21
Application Number : 50617
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROBIMYCIN
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1982-01-01
Application Number : 61633
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
